GlassScriptPhysician profile
Amandeep Kaur
NPI 1770870065
$2,771.09
in general payments reported to CMS, 2019-2025
10 companies · $424 in 2025
The $424 reported for 2025 was more than what 89% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $49.28 · 2021: $370 · 2022: $25.59 · 2023: $296 · 2024: $1,390 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,033 · Food and Beverage: $743 · Education: $325 · Gift: $8.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,033.14 |
| Food and Beverage | $742.66 |
| Education | $325.00 |
| Gift | $8.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,482.59 | 2022-2025 | |
| Straumann USA LLC | $348.53 | 2023-2025 | |
| Dentsply Sirona INC | $284.00 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $245.98 | 2019-2021 | |
| Align Technology, INC. | $200.78 | 2024-2025 | Invisalign |
| Voco America INC. | $128.27 | 2019-2025 | Admira Fusion X-Tra, Bifix Se, V-Posil |
| Kerr Corporation | $34.17 | 2020-2023 | Optibond All-In-One |
| Nobel Biocare USA | $22.95 | 2023 | Nobelactive |
| Colgate Oral Pharmaceuticals, INC. | $12.28 | 2022 | |
| Philips North America LLC | $11.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amandeep Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.